Portola Pharmaceuticals, Inc. Discovering and developing novel therapeutics.
Company Paglalarawan:
portola pharmaceuticals is a biopharmaceutical company developing innovative drugs for the treatment of cardiovascular and inflammatory diseases portolaõs two most advanced programs are in phase ii clinical trials: 1) betrixaban, an oral, once-daily factor xa inhibitor being developed for stroke prevention in patients with atrial fibrillation (spaf) and for prevention of venous thromboembolism (vte) in various patient populations, and 2) elinogrel, a direct-acting, reversible oral and i.v. adp receptor antagonist initially being developed for patients with acute coronary syndrome (acs).
Mga keyword sa paghahanap:
biopharmaceutical company, innovative drugs, treatment of cardiovascular diseases, inflammatory diseases, betrixaban, factor xa inhibitor, stroke prevention, atrial fibrillation, prevention of venous thromboembolism, elinogrel, oral and i.v. adp receptor antagonist, acute coronary syndrome, antithrombotic, thrombosis, inflammatory diseases
Company Address :
4941 Page Ave,MICHIGAN CENTER,MI,USA
ZIP Code : Postal Code :
49254-1156
Numero ng Telepono :
5177640973 (+1-517-764-0973)
Numero ng Fax:
5177645554 (+1-517-764-5554)
website:
www. portola. com
email:
USA tama Code ( Standard Industrial Classification Code ) :
kopyahin at ilagay ang google mapa na ito sa iyong website o blog!
Pindutin ang pindutan ng kopya at i-paste sa iyong blog o website.
(Mangyaring lumipat sa mode na ' HTML ' kapag nagpo-post sa iyong blog. Examples: WordPress Example, Blogger Example)
Makipag - ugnay sa ang potensyal dealer na ito , bumibili , nagbebenta , tagapagtustos , tagagawa, tagaluwas , mang-aangkat
(Input bumili , magbenta , quote para sa mga produkto o serbisyo)